Advanced Biologics L.L.C.

Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing.
PR Newswire; 8/27/2009; 972 words; ...Listing Rule 5250(c)(1). Encorium...Listing Rule 5250(c)(1). About Encorium...team management and advanced technologies. The Company has drug and biologics development as well...CONTACT: Philip L. Calamia, Chief Financial...

GNVC, PGNX, GST, EXLP, LLNW, TMRK Expected To Be Lower After Earnings Releases on Thursday.
M2 Presswire; 8/3/2009; 3234 words; ...on Thursday(C)1994-2009...Exterran Partners, L.P. 12 quarters...candidate, TNFerade biologic, is under Phase...inoperable, locally advanced pancreatic cancer...evaluating TNFerade biologic, wfor the treatment...constipation (OIC) in advanced illness patients...

PURE Bioscience Announces the Cleveland Clinic Has Taken an Equity Stake in FTA Therapeutics.
Business Wire; 7/30/2009; 1751 words; ...working with FTA." Michael L. Krall, President and...formulation and design of an advanced generation of free-ion...formerly President of Venture Biologics, a management and consulting...Balsamo, M.D., F.A.C.S., Geisinger Specialty...

"Stocks that Standout" picks for today are: ENCO, EWRC, NTMI, TEG, WAVX.
M2 Presswire; 7/17/2009; 3495 words; ...EWRC, NTMI, TEG, WAVX(C)1994-2009 M2 COMMUNICATIONS...announced the departure of Linda L. Nardone, Ph.D., Encorium...experienced team management and advanced technologies. The Company has drug and biologics development as well as clinical...

MERSANA REPORTS PRELIMINARY PHASE 1 RESULTS OF XMT-1001.(Financial report)
AsiaPulse News; 6/5/2009; 1439 words; ...in patients with advanced solid tumors...to patients with advanced solid tumors. By E. Sausville, L. Garbo, G. J...Yurkovetskiy, C. Bethune, R...Level 2, West Hall C About Fleximer...small molecules and biologics. Fleximer(R...